The Festival of Biologics USA meeting wrapped up last Thursday, and the emphasis was all about biosimilar sustainability, and the various factors threatening it. These included not only challenges but the opportunities that will be lost should we continue on our present path. In this post, I report on some of the most salient sessions, … Continue reading Biosimilar Topics at the Festival of Biologics: Part 1: Savings, Retinal Specialist Education, and Falling ASPs